Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

So why did Krishna Menon lie, and why

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Ligander Member Profile
Followed By 0
Posts 190
Boards Moderated 0
Alias Born 02/23/11
160x600 placeholder
NanoViricides Files Quarterly Report for Period Ending December 31, 2017 PR Newswire (US) - 2/21/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/20/2018 1:55:19 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 2/14/2018 5:57:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2017 10:29:10 AM
Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates PR Newswire (US) - 12/6/2017 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/22/2017 4:23:23 PM
NanoViricides Files Quarterly Report for Period Ending September 30, 2017 PR Newswire (US) - 11/20/2017 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2017 5:25:18 PM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 11/8/2017 5:18:02 PM
NanoViricides Provides Further Details on Its Herpes-Induced Acute Retinal Necrosis Animal Study to be Presented On November ... PR Newswire (US) - 11/6/2017 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/27/2017 6:08:02 AM
Excellent Results in Inhibiting Shingles Virus in Human Skin: NanoViricides Extends Agreement with SUNY Upstate Medical Cente... PR Newswire (US) - 10/26/2017 7:00:00 AM
NanoViricides to Present Results On Successful Treatment Of Herpes-Induced Acute Retinal Necrosis at the Annual Meeting of th... PR Newswire (US) - 10/17/2017 7:00:00 AM
NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials PR Newswire (US) - 9/29/2017 7:30:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 9/28/2017 4:51:22 PM
NanoViricides, Inc. Announces its CEO Dr. Seymour to Present at the 19th Annual Rodman & Renshaw Global Investment Conference... PR Newswire (US) - 9/11/2017 9:04:00 AM
NanoViricides Reports Its Drug Candidates Significantly Reduced the Extent of Shingles Virus Infection of Human Skin PR Newswire (US) - 7/10/2017 7:00:00 AM
NanoViricides' Poster "Novel NanoviricidesĀ® Highly Effective Against Varicella Zoster Virus in Cell Culture" to be Presented... PR Newswire (US) - 6/26/2017 9:00:00 AM
NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of Virology PR Newswire (US) - 6/20/2017 7:00:00 AM
NanoViricides CEO to Present Information on Its Topical Shingles Treatment At the 2017 Marcum Investor Conference in New York... PR Newswire (US) - 6/13/2017 7:00:00 AM
NanoViricides Reports Excellent Inhibitory Effects of Its Topical Shingles Treatment Candidates Against VZV in Multiple Cell ... PR Newswire (US) - 6/6/2017 5:30:00 PM
NanoViricides Files Quarterly Report for Period Ending 2017-03-31 PR Newswire (US) - 5/16/2017 7:50:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2017 5:03:04 PM
NanoViricides CEO Dr. Seymour to Present an Update on the Company at The Planet Microcap Showcase - 2017 in Las Vegas; Compan... PR Newswire (US) - 4/26/2017 5:00:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/26/2017 6:02:18 AM
Ligander   Wednesday, 03/09/11 01:00:33 PM
Re: LilKahuna post# 47091
Post # of 138038 
So why did Krishna Menon lie, and why does NNVC still support him?

Saying he published articles about other drugs does not make him the inventor of Alimta. It's like asking if Menon ever made a table and hearing "well, he made 200 chairs".

Great, but that wasn't the question.

NVVC put out a press release sayung...

Dr. Menon is a well known Pharmaceutical Scientist and Executive. He was awarded the Employee of the Year, Presidents Award (1999) at Eli Lilly, where he was a co-inventor of two drugs GEMZAR and ALIMTA which account for nearly one billion dollars in annual sales. Prior to that, he was Senior Research Scientist at Bayer. At present, he is on the board of directors of KARD Scientific, MA, and Biological Supplies, NY, and scientific advisor to Nexus Pharmaceuticals.

We now know that this information is false. He certainly wasn't "co-inventor" of those drugs. His name appears nowhere on the patents. Those who actually invented the drugs say he had a minor role.

Menon admits himself that he lied...

When asked about these inconsistencies during a brief follow up phone interview with Menon, he stood his ground, at least at first. "I am one of the creators" of the Eli Lilly drugs, he said at the start of the phone call.But as the conversation progressed, he began to downplay his role to that of a member of a team that developed the drugs, and finally explained that his work was actually limited to animal testing.

Contrary to the claims of some here, the magazine never issued a retraction of the article.

NNVC also claimed Menon holds patents that nobody can find:

Why, if these claims are true, does NNVC no longer make them?

Why, since they know they he has lied about his research history, does NNVC employ him to do their research?

In the future, Feelgood, please put some evidence behind your claims.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist